In Washington, researchers used blood from a National Children’s Study biobank to identify more accurate reference intervals for various hormones and amino acids in newborns across a diverse population. The more defined reference intervals could help with earlier diagnosis of diseases like diabetes and pediatric cancer as well as lead to a better understanding of physical and neurological development. As we know, newborns are tiny and its often difficult to draw a significant amount of blood from them for testing, which has proven to be a challenge in the past for researchers to have enough blood to test and reference. The hope is with this research, doctors will have a more accurate reference interval to refer to when testing pediatric patients for developmental issues or diseases.
Latest article
Ajinomoto combines two biotech ingredients in futuristic latte
                    In Singapore, iced lattes made from beanless coffee and cow-free proteins pulled from air will be available shortly in a preview at the country’s...                
            San Fran hotspot Fiorella hosts Mission Barns’ first cultivated pork sale
                    In California, cultivated meat maker Mission Barns has sold its pork for the first time at an exclusive dinner at San Francisco hot spot...                
            Uluu raises $10.4M to scale seaweed-based plastic
                    In Australia, seaweed-based plastic startup Uluu has raised AU$16 million (US$10.4 million) to build a demonstration plant to prove the viability of its technology.
Uluu’s...